Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Neoplasms, Unknown Primary 1Lung Neoplasms 1Kidney Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 19Nivolumab 16Cyclophosphamide 9Specimen Handling 7Ipilimumab 7atezolizumab 6fludarabine 5Magnetic Resonance Spectroscopy 5durvalumab 3avelumab 3X-Rays 3Biopsy 3ulixertinib 2sargramostim 2poly ICLC 2lenvatinib 2epacadostat 2enzalutamide 2cemiplimab 2cabozantinib 2budigalimab 2aldesleukin 2Trastuzumab 2Sirolimus 2Paclitaxel 2Melphalan 2Interleukin-2 2Immunoglobulin G 2Immune Checkpoint Inhibitors 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Genetic Profile × Dermatologic × Clear all
NCT03301493 2025-04-10

Genomic Testing and Resulting Medical Decisions

Arbeitsgemeinschaft medikamentoese Tumortherapie

Completed
1,500 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡